StockMarketWire.com - BioPharma Credit has announced a proposal to issue up to 152,375,471 ordinary shares on a non pre-emptive basis.

It said the shares would be at US$1.0114 which was the most recently published NAV per share (adjusted for the dividend declared by the company on 7 Dec, with ex-dividend date on 14 Dec), plus a premium to cover the costs of the issue.

It said net proceeds to be used to finance future investments in addition to commitments already made to Tesaro, Lexicon and Bristol Myers Squibb.


At 9:58am: [LON:BPCR] Biopharma Credit Plc share price was 0p at 1.04p



Story provided by StockMarketWire.com